The “Other” Effects of Psychotropic Medication: Social Workers’ Perspectives on the Psychosocial Effects of Medication Treatment on Adolescent Clients

Child and Adolescent Social Work Journal - Tập 25 - Trang 205-225 - 2008
Tally Moses1
1School of Social Work, University of Wisconsin-Madison, Madison, USA

Tóm tắt

This study explores social workers’ perspectives on the psychosocial effects of psychotropic drug treatment of their adolescent clients. Using a mail survey, we asked a national sample of experienced clinical social workers to answer questions about their perceptions of the effects of such treatment on the sense of self and social well-being of an adolescent client. The survey questions also explored associations between perceived psychosocial medication effects and characteristics of the client and the treatment. The findings suggested that social workers viewed medication treatment as having greater beneficial than harmful psychosocial effects on their adolescent clients, but that both effects existed simultaneously. The most important factors associated with the perceived effects of medication that emerged from social workers’ reports included the etiology of the disorder, the type of drug treatment and its effectiveness in addressing symptoms, the client’s “competence,” and the quality of the relationship between the client and the treating social worker. This study provides direction for future research on a neglected but important question. It would be helpful to broaden the scope of professional discourse on the advantages and disadvantages of psychopharmacologic treatment for youth beyond the effectiveness or safety of the treatment to include questions concerning clinicians’ perceptions of the effects of drug treatment on youths’ sense of self and social well-being.

Tài liệu tham khảo

Angermeyer, M., Daeumer, R., & Matschinger, H. (1993). Benefits and risks of psychotropic medication in the eyes of the general public: Results of a survey in the Federal Republic of Germany. Pharmacopsychiatry, 26(4), 114–120. Angold, A., Costello, E. J., & Erkanli, A. (1999). Comorbidity. Journal of Child Psychology and Psychiatry, 40, 57–87. Bastiaens, L. (1995). Compliance with pharmacotherapy in adolescents: Effects of patients’ and parents’ knowledge and attitudes toward treatment. Journal of Child and Adolescent Psychopharmacology, 5(1), 39–48. Baxley, G., Turner, P., & Greenwold, W. (1978). Hyperactive children’s knowledge and attitudes concerning drug treatment. Journal of Pediatric Psychology, 8, 172–176. Bentley, K., & Walsh, J. (2006). The social worker and psychotropic medication. New York: Brooks/Cole. Berg, W. E., & Wallace, M. (1987). Effect of treatment setting on social workers’ knowledge of psychotropic drugs. Health and Social Work, 12(2), 144–152. Bernstein, G. A., Anderson, L. K., Hektner, J. M., & Realmuto, G. M. (2000). Imipramine compliance in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 39(3), 284–291. Boice, M. M. (1998). Chronic illness in adolescence. Adolescence, 33(132), 927–939. Borden, K. A., & Brown, R. T. (1989). Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research, 13(2), 147–160. Clarke, C. H. (1998). An exploratory study of the meaning of prescription medication to children diagnosed with attention deficit hyperactivity disorder. Unpublished doctoral dissertation, Loyola University, Chicago. Cohen, N. J., & Thompson, L. (1982). Perceptions and attitudes of hyperactive children and their mothers regarding treatment with methylphenidate. Canadian Journal of Psychiatry, 27(1), 40–42. Costello, I., Wong, I., & Nunn, A. (2004). A literature review to identify interventions to improve the use of medicines in children. Child: Care, Health and Development, 30(6), 647–665. Cromer, B., & Tarnowski, K. (1989). Noncompliance in adolescents: A review. Journal of Developmental and Behavioral Pediatrics, 10(4), 207–215. Doherty, S., Frankenberger, W., Fuhrer, R., & Snider, B. (2000). Children’s self reported effects of stimulant medication. International Journal of Disability, Development, and Education, 47, 39–54. Floersch, J. (2003). The subjective experience of youth psychotropic drug treatment. Social Work in Mental Health, 1(4), 51–70. Frankenberger, W. (2001). Use of stimulant medication for treatment of attention-deficit/hyperactivity disorder: A survey of middle and high school students’ attitudes. Psychology in the Schools, 38(6), 569–584. Garb, H. (1998). Studying the clinician: Judgment research and psychological assessment. Washington, DC, US: American Psychological Association. Garfield, S., Smith, F., & Francis, S. (2003). The paradoxical role of antidepressant medication—returning to normal functioning while losing the sense of being normal. Journal of Mental Health, 12(5), 521–535. Goldstein, M. (1992). Psychosocial strategies for maximizing the effects of psychotropic medications for schizophrenia and mood disorder. Psychopharmacology Bulletin, 28(3), 237–240. Hunkeler, E., Fireman, B., & Lee, J. (2005). Trends in the use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente insured youth, 1994–2003. Journal of Child and Adolescent Psychopharmacology, 15(1), 26–37. Ialongo, N., Lopez, M., Horn, W., Pascoe, J. et al. (1994). Effects of psychostimulant medication on self-perceptions of competence, control, and mood in children with attention deficit hyperactivity disorder. Journal of Clinical Child Psychology, 23(2), 161–173. Jellinek, M. (2003). Mirror, mirror on the wall: Are we prescribing the right psychotropic medications to the right children using the right treatment plan? Archives of Pediatrics and Adolescent Medicine, 157, 14–16. Jensen, S., Kettle, L., Roper, M. T., Sloan, M. T., Dulcan, M. K., Hoven, C., Bird, H. R., Bauermeister, J. J., & Payne, J. D. (1999). Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. Journal of the American Academy of Child and Adolescent Psychiatry, 38(7), 797–804. Johnston, C., Fine, S., Weiss, M., Weiss, J., Weiss, G., & Freeman, W. S. (2000). Effects of stimulant medication treatment on mother’s and children’s attributions for the behavior of children with attention deficit hyperactivity disorder. Journal of Abnormal Child Psychology, 28(4), 371–382. Karp, D. (1996). Speaking of sadness. New York: Oxford University Press. Kendall, J., Hatton, D., & Beckett, A. (2003). Children’s accounts of attention-deficit/hyperactivity disorder. Advances in Nursing Science, 26(2), 114–130. Kilian, R., & Angermeyer, M. (1999). Quality of life in psychiatry as an ethical duty: From the clinical to the societal perspective. Psychopathology, 32(3), 127–134. King, C. A., Hovey, J. D., Brand, E., Wilson, R, & Ghaziuddin, N. (1997). Suicidal adolescents after hospitalization: Parent and family impacts on treatment follow-through. Journal of the American Academy of Child and adolescent Psychiatry, 36(1), 85–93. Leavey, J. (2003). The meaning of mental illness to youth: Exploring the psychosocial effects of mental illness on identity and life cycle development in youth aged 17–24. Unpublished dissertation, University of Toronto. Littrell, J., & Ashford, J. (1994). The duty of social workers to refer for medications: A study of field instructors. Social Work Research, 18(2), 123–128. Lloyd, A., Horan, W., Borgaro, S. R., Stokes, J. M., Pogge, D. L., & Harvey, D. (1998). Predictors of medication compliance after hospital discharge in adolescent psychiatric patients. Journal of Child and Adolescent Psychopharmacology, 8(2), 133–141. Manderscheid, R., & Henderson, M. (2000). Mental health, United States. Rockville, MD: Center for mental Health Services, DHHS. Martin, A., Van Hoof, T., Stubbe, D., Sherwin, T., Scahill, L. (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatric Services, 54(1), 72–77. Masi, G., Marcheschi, M., & Luccherino, L. (1996). Psychotropic medication in adolescence: Psychodynamic and clinical considerations. Adolescence, 31(124), 925–933. McCabe, M. (1996). Involving children and adolescents in medical decision making: Developmental and clinical considerations. Journal of Pediatric Psychology, 21(4), 505–516. Mertler, C., & Vannatta, R. (2002). Advanced and multivariate statistical methods. Los Angeles: Pyrczak publishing. Milich, R., Carlson, C., Pelham, W., & Licht, B. (1991). Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology, 19(5), 519–536. Moline, S., & Frankenberger, W. (2001). Use of stimulant medication for treatment of attention-deficit/hyperactivity disorder: A survey of middle and high school students’ attitudes. Psychology in the Schools, 38(6), 569–584. Moses, T., & Kirk, S. (2005). Psychosocial drug effects of drug treatment of youth. In S. A. Kirk (Ed.), Mental disorders in the social environment: Critical perspectives. New York: Columbia University Press. Moses, T. & Kirk, S. (2008). Social work roles in drug treatment with youth. Social Work in Mental Health, 6(3), 59–81. Moses, T., & Kirk, S. A. (2006). Social workers’ attitudes about psychotropic drug treatment with youth. Social Work, 51(3), 211–222. Pelham, W., Kipp, H., Gnagy, E., Hoza, B., et al. (1997). Effects of methylphenidate and expectancy on ADHD children’s performance, self-evaluations, persistence, and attributions on a cognitive task. Experimental and Clinical Psychopharmacology, 5(1), 3–13. Pugh, R., Ackerman, B., McColgan, E., et al. (1994). Attitudes of adolescents toward adolescent psychiatric treatment. Journal of Child and Family Studies, 3(4), 351–363. Rappaport, N., & Chubinsky, P. (2000). The meaning of psychotropic medications for children, adolescents, and their families. Journal of the American Academy of Child and Adolescent Psychiatry, 39(9), 1198–1200. Robison, L., Sclar, D., & Skaer, T. (2004). Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99. International Clinical Psychopharmacology, 19(1), 17–22. Safer, D., Zito, J., & dosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160(3), 438–449. Schowalter, J. (1989). Psychodynamics and medication. Journal of the American Academy of Child and Adolescent Psychiatry, 28(5), 681–684. Scott, C., Lore, C., & Owen, R. (1992). Increasing medication compliance and peer support among psychiatrically diagnosed students. Journal of School Health, 62(10), 478–480. Skaer, T., Robison, L., Sclar, D., & Galin, R. (2000). Treatment of depressive illness among children and adolescents in the United States. Current Therapeutic Research, 61(10), 692–705. Sparks, J. (2001). Taking a stand: An adolescent girl’s resistance to medication. Journal of Marital and Family Therapy, 28(1), 27–38. Staller, J., Wade, M., & Baker, M. (2005). Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York. Journal of Child and Adolescent Psychopharmacology, 15(1), 57–61. Thomas, C., Conrad, P., & Casler, R. (2005). Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiatric Services, 57(1), 63–69. Venarde, D. F. (1999). Medication and meaning: Psychotherapy patients’ subjective experiences of taking selective serotonin reuptake inhibitors. Unpublished doctoral dissertation, The Graduate School of Applied and Professional Psychology of Rutgers University, New Jersey. Vitiello, B. (2001). Long-term effects of stimulant medications on the brain: Possible relevance to the treatment of attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 11(1), 25–34. Walkup, J. T. (2003). Increasing use of psychotropic medications in children and adolescents: What does it mean? Journal of Child and Adolescent Psychopharmacology, 13(1), 1–3. Whalen, C., & Henker, B. (1976). Psychostimulants and Children: A Review and Analysis. Psychological Bulletin, 83(6), 1113–1130. Wolraich, M. (2001). Increased psychotropic medication use: Are we improving mental health care or drugging our kids? Archives of Pediatrics and Adolescent Medicine, 155, 5. Worthington, R., & Atkinson, D. (1993). Counselors’ responsibility and etiology attributions, theoretical orientations, and counseling strategies. Journal of Counseling Psychology. 40(3), 295–302. Zito, J., & Safer, D. (2001). Services and prevention: Pharmacoepidemiology of antidepressant use. Biological Psychiatry, 49(12), 1121–1127.